Company intelligence / Profile preview

PharSafer

Ripley/Woking, Surrey, United Kingdompharsafer.com ↗

Ownership: Private
Development stage: Commercial

Overview

PharSafer® specializes in global clinical and post-marketing drug safety, offering comprehensive pharmacovigilance services including case processing, literature review, signal detection, risk management plans, periodic report writing, medical device safety support, and regulatory compliance consulting. The company has processed over 750,000 cases and written/processed more than 6,000 aggregate reports. It serves clients worldwide with high accuracy rates in compliance. No direct clinical results as it does not develop drugs itself.

Modalities: Small molecules (drugs)Biologics (including vaccines)Medical devicesAdvanced therapy products (e.g., ATMPs)Cosmetics
Industry: Contract Research Organization

Partnerships

Strategic partners globally to extend service offerings beyond core expertise when needed.

Beyond the preview

Go deeper on PharSafer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharSafer.

Explore the full profile